PepGen Inc
PEPG
NASDAQ
Biotechnology
$2.99
USD
+0.01 (+0.34%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $206.39M
Volume 612.4K
Price Target
$11.00 – $11.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $11.00 and a min estimate of $11.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$11.00
+$2.3 vs prior
Implied Upside
+267.9%
+77.9% vs prior
Analyst Covering
1
-2 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
25%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Adam Vogel | Craig-Hallum | Buy | Initiated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
ABOS
Acumen Pharmaceuticals Inc
$2.67
▲ +4.7%
KROS
Keros Therapeutics Inc
$10.10
▼ -5.3%
KRRO
Korro Bio Inc
$13.28
▼ -0.1%
VYGR
Voyager Therapeutics Inc
$3.27
▲ +1.6%
WHWK
Whitehawk Therapeutics Inc
$4.46
▼ -4.7%
IVVD
Invivyd Inc
$0.7200
▲ +5.1%
TNXP
Tonix Pharmaceuticals Holding Corp
$12.71
▲ +1.7%
CRBP
Corbus Pharmaceuticals Holdings Inc
$10.09
▲ +0.1%
DTIL
Precision BioSciences Inc
$7.43
▲ +1.8%
PYXS
Pyxis Oncology Inc
$3.01
▲ 0.0%